Subscribe to Moneycontrol Pro and get 365 bonus InterMiles! Use Code: INTERMILES
Last Updated : Oct 01, 2020 10:48 PM IST | Source: PTI

India's exports snap six-month losing streak, rise 5.27% in September

Goyal said this is an indicator of the "rapid recovery" of the Indian economy as it surpasses pre-COVID-19 levels across parameters.


After contracting for six months in a row, the country's exports grew by 5.27 percent to $27.4 billion in September, Commerce and Industry Minister Piyush Goyal said on October 1.

He said this is an indicator of the "rapid recovery" of the Indian economy as it surpasses pre-COVID-19 levels across parameters. "Make in India, Make for the World: Indian merchandise exports grew 5.27 percent in September 20 as compared to last year," he said in a tweet.

In September 2019, the exports stood at $26.02 billion. Since March, the country's outbound shipments were recording negative growth due to the COVID-19 pandemic and the resultant fall in global demand.


Key sectors such as petroleum, leather, engineering goods and gems and jewellery were registering negative growth rates. Commenting on the numbers, Trade Promotion Council of India (TPCI) Chairman Mohit Singla said exports are on the path of recovery as the international market is opening up and buyers have started placing orders.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

"Food and agri sector will continue to thrust exports as they have done in even the worst of times in the past," Singla added. Federation of Indian Export Organisations (FIEO) President Sharad Kumar Saraf said "this was expected due to anti-China sentiments as a lot of orders have come."

He added that exporters can do much better if issues pertaining to Merchandise Exports from India Scheme (MEIS), risky exporters and RoDTEP (Remission of Duties and Taxes on Exported Products) are resolved.

Follow our full coverage of the coronavirus pandemic here.
First Published on Oct 1, 2020 10:48 pm